is tirzepatide on the market yet Compounded Injections $100 FDA confirms tirzepatide shortage is

Activation of GLP-1 receptors is known to increase intracellular cAMP and stimulate PKA activity in several tissue types, including neurons

Loss or damage to the ICCs appears to be a dominant abnormality [3, 6, 11], where altered immune function with a shift from M2 to M1 macrophage expression and impaired regulation of haem oxygenase 1 leading to increased oxidative stress may be responsible [6, 11]

These should be evaluated as brand-attributed testimonials, not independent endorsements

Median [IQR] follow-up times in the two groups were of 642 [2231,414] days in the GLP-1 RA group and 529 [2071,131] days in the DPP-4i group